Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).
- Conditions
- NSCLCLung NeoplasmCarcinomaLung Cancer
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2020-06-26
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT03634826
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
The Efficacy of Transcutaneous Electrical Nerve Stimulation on LUTS: One Prospective Study.
Not Applicable
- Conditions
- Pelvic Organ Prolapse
- Interventions
- Device: PHENIX4-8-8 PLUS
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT03634722
- Locations
- 🇨🇳
The Peking University People's Hospital, Beijing, Beijing, China
Pain Index Extracted From EEG in Monitoring Chronic Pain
Completed
- Conditions
- Chronic PainPain Assessment
- Interventions
- Diagnostic Test: Pain index
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2018-11-30
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 111
- Registration Number
- NCT03613012
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients
Completed
- Conditions
- Breast CancerSentinel Lymph NodeLocal Recurrence of Malignant Tumor of Breast
- Interventions
- Procedure: no further ALND arm
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2022-10-18
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 142
- Registration Number
- NCT03606616
- Locations
- 🇨🇳
Peking university people's hospital, Beijing, Bei Jing, China
PD-L1 Expression in Advanced Osteosarcoma
- Conditions
- ProgressionSurvival
- Interventions
- Other: all study participants
- First Posted Date
- 2018-07-11
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT03582527
- Locations
- 🇨🇳
Musculoskeletal Tumor Center of Peking University People's Hospital, Beijing, Beijing, China
Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer
Phase 1
- Conditions
- Recurrent Ovarian CarcinomaPlatinum-resistant Ovarian Cancer
- Interventions
- Drug: 6B11-OCIK Injection
- First Posted Date
- 2018-05-31
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT03542669
- Locations
- 🇨🇳
Peking University People's hospital, Beijing, China
Effect of Fertility-sparing Therapy of Early Endometrial Cancer
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2018-05-29
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT03538704
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Epidemiology and Psychosocial Evaluation of Inpatient With Lung Opacity
- Conditions
- Lung CancerPsychological Distress
- Interventions
- Other: Questionnaire Administration
- First Posted Date
- 2018-04-17
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT03498768
- Locations
- 🇨🇳
Peking University People'S Hospital, Beijing, Beijing, China
Effects of OCTA-guided PDT in Acute CSC
Not Applicable
Completed
- Conditions
- Central Serous ChorioretinopathyTomography, Optical Coherence
- Interventions
- Procedure: ICGA-guided Photodynamic therapyProcedure: OCTA-guided Photodynamic therapy
- First Posted Date
- 2018-04-12
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT03497000
- Locations
- 🇨🇳
People's Hospital of Peking University, Beijing, Beijing, China
Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
- First Posted Date
- 2018-04-09
- Last Posted Date
- 2018-04-10
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 56
- Registration Number
- NCT03491371
- Locations
- 🇨🇳
Musculoskeletal Tumor Center of Peking University People's Hospital, Beijing, China
🇨🇳Peking University Shougang Hospital, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath